ArticleCureus2026

Ocrelizumab Discontinuation After Recurrent Serious Infections in Clinically Stable Primary Progressive Multiple Sclerosis: A Case Report.

Tyler Lo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.